A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]
about
Calcitonin testing for detection of medullary thyroid cancer in patients with thyroid nodulesRecombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancerCancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisionsSelective use of sorafenib in the treatment of thyroid cancerWhat is the Minimal Surgery for Papillary Thyroid Carcinoma?Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid CarcinomaTERT promoter mutations in thyroid cancerThe rare intracellular RET mutation p.Ser891Ala in an apparently sporadic medullary thyroid carcinoma: a case report and review of the literatureCabozantinib for progressive metastatic medullary thyroid cancer: a reviewTreatment strategies for radioactive iodine-refractory differentiated thyroid cancerImaging of thyroid carcinoma with CT and MRI: approaches to common scenariosProgress in molecular-based management of differentiated thyroid cancerOverview and management of dermatologic events associated with targeted therapies for medullary thyroid cancerHürthle cell carcinoma: current perspectivesThyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapyA meta-analysis on the effect of operation modes on the recurrence of papillary thyroid microcarcinomaAssociation of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancerSignificance of the Extracapsular Spread of Metastatic Lymph Nodes in Papillary Thyroid CarcinomaPreoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinomaIntegrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomasOncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerMultiple endocrine neoplasia type 2 kindred with novel tandem RET mutations: Case report with an applied in silico mutational tolerance analysis.Conservative management of well-differentiated thyroid cancerAcoustic Radiation Force Impulse Elastography: A Useful Tool for Differential Diagnosis of Thyroid Nodules and Recommending Fine-Needle Aspiration: A Diagnostic Accuracy Study.Cancer Registries: Can We Improve the Quality of Thyroid Cancer Data?Risk assessment for benefits analysis: framework for analysis of a thyroid-disrupting chemical.Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern populationLack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinomaSporadic medullary thyroid carcinoma: clinical data from a university hospitalIncreasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markersGenomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancyLong-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancerRole of prophylactic central neck dissection in cN0 papillary thyroid cancer.Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.Utility of quantitative contrast-enhanced ultrasound for the prediction of extracapsular extension in papillary thyroid carcinoma.Ex vivo imaging of human thyroid pathology using integrated optical coherence tomography and optical coherence microscopy.Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.Prognostic utility of BRAF mutation in papillary thyroid cancer.
P2860
Q24198902-246B9F30-A80B-4829-B131-5CFBFC89DC83Q24236576-E50BC0A1-023A-4AD2-98E8-D3BBB69BFB02Q26261171-A04BEFBF-5B20-41C5-AC2D-2D5DBF5FE49FQ26752891-FAA0E594-B5B5-41EB-BF11-4533857E6001Q26765080-DEC5E7C5-0E26-4C5F-B416-58786C60EA21Q26765093-919A1645-4E05-42AA-9A82-50C570A59537Q26770808-B409D9F6-BC01-4327-BAE5-3D8DC27449CFQ26827963-C66E2C66-97E8-4D13-9B00-1AA4556C31FCQ26851709-C639571D-BF0D-4CBF-A58B-BD41B12B7390Q26862841-BC52E23A-F7B8-4C6E-B4C9-B3ADF6459773Q26995608-F640C658-8868-427D-A8BF-011368FEA1A6Q26999887-1F8B4DA9-CDE3-4D5A-B834-96CEACA76611Q27005701-9C1C870B-7162-457D-BA34-81599E805D52Q28069765-8B6C950B-9F19-4298-B9D3-E0436ED0C05FQ28071977-0360FE99-E0E8-4339-AF0C-C9B402A48A8AQ28072335-FF2023BA-B412-4508-8E84-84395FD6B38EQ28253304-451A4AB8-BDDB-4D85-A87A-C593B3100368Q28266858-9DEBB076-4E42-40F6-83D5-834C8D05614FQ28365618-1A7D7846-F17F-4B23-AFC8-95CEF43D0F07Q28475549-6B853BAF-07AD-4E6A-B522-B635B00B0831Q28756117-7146765C-328D-48FE-83ED-CB9EE2FFF53DQ30367068-A5EA0233-7CBB-4791-821E-EE7FCDFC3ADEQ30384468-1EAFAC36-A873-4E33-9FE2-D37F1A43DE96Q30387260-C13CAA7A-8F80-461B-9B48-3A73C566F4B4Q30400392-CEC40A30-C4B6-4AD1-AFAF-5E898297EDA2Q31136187-EFC71976-567C-4730-8383-9593F2A73847Q33219529-FAD05BFD-8B33-4F38-B2C2-1C889E72F8AAQ33349220-0459A357-DFC4-4E5E-9227-3644259A2E39Q33381498-822F2A09-C39B-4B6E-8E94-14C990856E92Q33458398-B6720A7F-D750-461D-B548-FD65D9ECA300Q33515256-899D45A9-09F2-41F5-87EE-C48ABE4EBBF1Q33570013-6023E52B-B6A3-4E49-BDC3-5B50BE909891Q33570297-239DAF88-5212-430C-9109-0B3F4EBCA5EEQ33587809-325E1562-3202-4D47-A1DE-32B69F6FB465Q33599870-BA6971E0-442A-480D-A5DD-85D2140FCBEFQ33680709-BAFC3ACE-D486-4887-85AC-069D1E6317F5Q33684552-F63E8F45-EC6D-4B6C-91FC-FEC645A18B34Q33747878-1F40A44A-9ACD-4F40-B091-C9807C2481C5Q33771043-EF927B0F-787A-41D4-8391-0F67DBFB69CFQ33771120-32E95E32-6B84-45E3-916C-37C625171F77
P2860
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A National Cancer Data Base re ...... U.S., 1985-1995 [see commetns]
@ast
A National Cancer Data Base re ...... U.S., 1985-1995 [see commetns]
@en
type
label
A National Cancer Data Base re ...... U.S., 1985-1995 [see commetns]
@ast
A National Cancer Data Base re ...... U.S., 1985-1995 [see commetns]
@en
prefLabel
A National Cancer Data Base re ...... U.S., 1985-1995 [see commetns]
@ast
A National Cancer Data Base re ...... U.S., 1985-1995 [see commetns]
@en
P2093
P2860
P1433
P1476
A National Cancer Data Base re ...... U.S., 1985-1995 [see commetns]
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1
P407
P577
1998-12-01T00:00:00Z